TAT-mediated transduction of NF-Ya peptide induces the ex vivo proliferation and engraftment potential of human hematopoietic progenitor cells
Authors:
- 14 October 2010
- journal article
- Published by American Society of Hematology in Blood
- Vol. 116 (15) , 2676-2683
Abstract
Retroviral overexpression of NF-Ya, the regulatory subunit of the transcription factor NF-Y, activates the transcription of multiple genes implicated in hematopoietic stem cell (HSC) self-renewal and differentiation and directs HSCs toward self-renewal. We asked whether TAT-NF-Ya fusion protein could be used to transduce human CD34+ cells as a safer, more regulated alternative approach to gene therapy. Here we show that externally added recombinant protein was able to enter the cell nucleus and activate HOXB4, a target gene of NF-Ya, using real-time polymerase chain reaction RNA and luciferase-based protein assays. After TAT-NF-Ya transduction, the proliferation of human CD34+ cells in the presence of myeloid cytokines was increased 4-fold. Moreover, TAT-NF-Ya-treated human primary bone marrow cells showed a 4-fold increase in the percentage of huCD45+ cells recovered from the bone marrow of sublethally irradiated, transplanted NOD-Scid IL2Rγnull mice. These data demonstrate that TAT-peptide therapies are an alternative approach to retroviral stem cell therapies and suggest that NF-Ya peptide delivery should be further evaluated as a tool for HSC/progenitors ex vivo expansion and therapy.Keywords
This publication has 50 references indexed in Scilit:
- Twenty years of cell‐penetrating peptides: from molecular mechanisms to therapeuticsBritish Journal of Pharmacology, 2009
- Posttranslational Regulation of NF-YA Modulates NF-Y Transcriptional ActivityMolecular Biology of the Cell, 2008
- Excision of selectable genes from transgenic goat cells by a protein transducible TAT-Cre recombinaseGene, 2008
- High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vectorJournal of Clinical Investigation, 2008
- Clustering of DNA Sequences in Human PromotersGenome Research, 2004
- Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteinsBiochemical and Biophysical Research Communications, 2004
- Rapid screening for improved solubility of small human proteins produced as fusion proteins in Escherichia coliProtein Science, 2002
- In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the MouseScience, 1999
- Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migrationNature Medicine, 1998
- Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator proteinCell, 1988